Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dubravka.pezic@labgeni.us
    Junior Member
    • Apr 2022
    • 2

    #1

    quality score issues

    Hi all,

    i am wondering what are possible causes of low Q30 scores, apart from overclustering?

    I am working with amplicon libraries which were sequenced on MiSeq using v2 500 PE kit. I sequenced 12 libraries, all prepared simultaneously using the same method. PhiX comprised 21% of the run. The run metrics looked good with avg Q30 of 88%, and the output was very high with nearly 43 million PE reads (expected 25-30 mil). Cluster density was high, about 1,200 K/mm2 which is the upper end for this kit, but ~94% reads passed filter.
    However when I ran FastQC on my samples I got very poor per base quality scores for some libraries (but not all!). For some libraries the scores were worse for Read 1, and for others for Read 2. This resulted in a lot of data being discarded.
    It basically looks like Q30 data from BaseSpace (where median Q30 score is low only for late cycles for each read) does not match with quality scores given by FastQC.

    I would be grateful for any insight as to why this would happen!

    Many thanks,
    Dubravka

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...